Marshall Wace »

Relmada Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2023-12-31 $636k 154k 4.14
2022-09-30 $3.6M 96k 37.05

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Alphabet Inc-a Equity Option Put Option (GOOGL)
Meta Platforms-a Common Stock (META)
Alphabet Inc-c Common Stock (GOOG)
Walmart Common Stock (WMT)
Abbvie Equity Option Put Option (ABBV)
Las Vegas Sands Common Stock (LVS)
Dr Horton Common Stock (DHI)
Ishares-leh 20 Equity Option Call Option (TLT)
Eli Lilly & Co Right Call Option
General Electric Common Stock (GE)

View all positions for Marshall Wace

Top funds holding Relmada Therapeutics

Vanguard Group
Parsons Capital Management
Opaleye Management
Palo Alto Investors
Citadel Advisors
Two Sigma Advisers
Two Sigma Investments
Point72 Asset Management
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Bank of America Corporation
Millennium Management
Guild Investment Management
Marshall Wace
Barclays

View all funds holding Relmada Therapeutics